Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 04, 2022

SELL
$15.51 - $29.31 $110,446 - $208,716
-7,121 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$27.47 - $37.31 $1,538 - $2,089
56 Added 0.79%
7,121 $203,000
Q2 2021

Aug 02, 2021

BUY
$25.45 - $37.64 $179,804 - $265,926
7,065 New
7,065 $239,000
Q1 2021

May 06, 2021

SELL
$29.16 - $51.96 $169,186 - $301,471
-5,802 Closed
0 $0
Q4 2020

Jan 28, 2021

SELL
$37.86 - $54.26 $7,420 - $10,634
-196 Reduced 3.27%
5,802 $287,000
Q3 2020

Nov 05, 2020

BUY
$35.13 - $43.62 $210,709 - $261,632
5,998 New
5,998 $230,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $342M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.